Investigating the Role of IL-23R in Mucosal Regulatory T Cells
研究 IL-23R 在粘膜调节 T 细胞中的作用
基本信息
- 批准号:10214607
- 负责人:
- 金额:$ 12.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-10 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesAntibodiesAntigen-Presenting CellsApplications GrantsAttenuatedAutomobile DrivingBacteriaBiologicalBone MarrowCD4 Positive T LymphocytesCause of DeathCell RespirationCell physiologyCellsCellular Metabolic ProcessCellular biologyCessation of lifeChimera organismChronicClinicalColitisColon CarcinomaColorectal CancerComplementComplexCrohn&aposs diseaseDataData SetDendritic CellsDiseaseDisease remissionDisease susceptibilityEnterobacteria phage P1 Cre recombinaseEnvironmental Risk FactorEpigenetic ProcessEtiologyExhibitsFOXP3 geneFrequenciesFutureGastrointestinal tract structureGeneticGenetic TranscriptionGrantHomeostasisHumanIL12B geneImmuneImmune ToleranceImmune responseImmune systemImmunologic FactorsImmunologyImmunomodulatorsIncidenceInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInterleukin-12Interleukin-17Intestinal DiseasesIntestinesInvestigationKnowledgeLarge IntestineLesionLifeLinkLoxP-flanked alleleLymphocyteLymphoid CellMaintenanceMalignant NeoplasmsMediatingMentored Research Scientist Development AwardMentorsMetabolicMetabolic PathwayMetabolismMicrobial GeneticsMitochondriaModelingMucosal ImmunityMucous MembraneMusNatureNuclear Orphan ReceptorOrganPathogenesisPathogenicityPathway interactionsPatientsPhase III Clinical TrialsPlacebosPopulationPopulation DynamicsPostdoctoral FellowPredispositionProductionPrognosisPublishingRectal CancerRefractoryRegulatory T-LymphocyteRelapseReporterReportingResearchResearch PersonnelRespirationRetinoic Acid ReceptorRiskRoleSignal PathwaySignal TransductionSiteSourceSuperoxidesT-LymphocyteTherapeuticTranscriptUlcerative ColitisUnited StatesVariantWorkcarcinogenesiscell typecytokinedisorder riskgenome wide association studyhumanized mouseimmunoregulationimprovedin vivoinflammatory disease of the intestineinnovationinterleukin-23macrophagemouse modelpreventprogramspromoterreceptorreceptor expressionresponsesingle-cell RNA sequencingsuccessful interventionsystemic interventiontherapeutically effectivetumor
项目摘要
Project Summary
Dysregulated immune responses to luminal bacteria in the intestine are largely responsible for the chronic
nature of inflammatory bowel disease (IBD). Attenuating the inflammatory response via immunomodulators
and/or biologics represent the majority of therapeutic strategies to induce remission. However, many patients
either do not respond and those that initially do often stop responding. Restoring immune tolerance by
increasing regulatory T cell (Treg) numbers or improving Treg function may be a viable strategy to achieve
long-term remission. The PI’s K01 award has focused on strategies to expand Tregs in vivo to prevent
experimental colitis in humanized mice. In the course of these studies, the cytokine interleukin-23 (IL-23) was
upregulated in murine and human antigen presenting cells. Consistent with a role for IL-23 in IBD, variants in
IL23R have been linked to IBD susceptibility. Furthermore, a recent phase 3 clinical trial in patients with
Crohn’s disease targeted the p40 subunit of IL-23 (also shared with IL-12) and reported significant
improvement in both induction and maintenance of clinical response and remission over placebo. Although
macrophage and dendritic cells in the intestine are the source of IL-23, expression of IL-23R is generally
restricted to lymphocytes and type 3 innate lymphoid cells (ILC3s). In this proposal, we will determine the role
of IL-23R in Tregs in intestinal immune homeostasis and during inflammation using mice harboring floxed Il23r
alleles combined with a Cre recombinase driven by the endogenous Foxp3 promotor. In Aim 1, we will
determine the role of IL-23R in FOXP3+ Tregs during inflammation and inflammation-associated
carcinogenesis. In Aim 2, we will define the transcriptional, metabolic, and signaling networks/pathways
modulated by IL-23R signaling in intestinal FOXP3+ cells. Overall, these studies explore in detail how IL-23R
differentially impacts mucosal immunity and it’s role during inflammation that will inform future therapeutic
strategies for IBD and colon cancer. This proposal will further advance the independent studies of the PI and
facilitate his transition as a successful investigator and leader in the field of mucosal immunology and will
provide sufficient published and preliminary data to facilitate a highly competitive application for a R01 grant
application as an early-stage investigator.
项目摘要
对肠腔细菌的免疫应答失调是导致慢性腹泻的主要原因。
炎症性肠病(IBD)的性质。通过免疫调节剂减弱炎症反应
和/或生物制剂代表了诱导缓解的大多数治疗策略。然而,许多患者
要么不响应,而那些最初响应的通常停止响应。恢复免疫耐受,
增加调节性T细胞(Treg)数量或改善Treg功能可能是实现以下目标的可行策略:
长期缓解。PI的K 01奖重点关注在体内扩大TcR的策略,以防止
人源化小鼠的实验性结肠炎。在这些研究的过程中,细胞因子白细胞介素-23(IL-23)被
在鼠和人抗原呈递细胞中上调。与IL-23在IBD中的作用一致,
IL 23 R与IBD易感性有关。此外,最近的一项在患有
克罗恩病靶向IL-23的p40亚单位(也与IL-12共享),并报告了显著性差异。
与安慰剂相比,在诱导和维持临床应答和缓解方面均有改善。虽然
肠中的巨噬细胞和树突状细胞是IL-23的来源,IL-23 R的表达通常是
仅限于淋巴细胞和3型先天淋巴样细胞(ILC 3)。在本提案中,我们将确定
IL-23受体在肠道免疫稳态和炎症过程中的表达
等位基因与由内源性Foxp 3启动子驱动的Cre重组酶组合。在目标1中,我们
确定IL-23 R在炎症和炎症相关性炎症过程中FOXP 3 + T细胞中的作用
致癌作用在目标2中,我们将定义转录,代谢和信号网络/途径
在肠FOXP 3+细胞中通过IL-23 R信号传导调节。总的来说,这些研究详细探讨了IL-23 R
差异影响粘膜免疫及其在炎症过程中的作用,这将为未来的治疗提供信息。
IBD和结肠癌的治疗策略。这一建议将进一步推动PI的独立研究,
促进他作为粘膜免疫学领域的成功研究者和领导者的转变,并将
提供足够的已发布和初步数据,以促进竞争激烈的R 01赠款申请
作为一个早期的调查员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeremy Allen Goettel其他文献
Jeremy Allen Goettel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeremy Allen Goettel', 18)}}的其他基金
Characterizing antibody responses to HIV-1 vaccination in next-generation immune humanized mice
表征下一代免疫人源化小鼠对 HIV-1 疫苗接种的抗体反应
- 批准号:
10673292 - 财政年份:2023
- 资助金额:
$ 12.98万 - 项目类别:
Investigating the Role of IL-23R in Mucosal Regulatory T Cells
研究 IL-23R 在粘膜调节 T 细胞中的作用
- 批准号:
10057505 - 财政年份:2020
- 资助金额:
$ 12.98万 - 项目类别:
Investigating cross-regulation of the microbiome and mucosal immune system using humanized mice
使用人源化小鼠研究微生物组和粘膜免疫系统的交叉调节
- 批准号:
9341288 - 财政年份:2015
- 资助金额:
$ 12.98万 - 项目类别:
Investigating cross-regulation of the microbiome and mucosal immune system using humanized mice
使用人源化小鼠研究微生物组和粘膜免疫系统的交叉调节
- 批准号:
9109630 - 财政年份:2015
- 资助金额:
$ 12.98万 - 项目类别:
Investigating cross-regulation of the microbiome and mucosal immune system using humanized mice
使用人源化小鼠研究微生物组和粘膜免疫系统的交叉调节
- 批准号:
9769013 - 财政年份:2015
- 资助金额:
$ 12.98万 - 项目类别:
Investigating the function of human regulatory cells in the intestinal mucosa of
研究人类肠粘膜调节细胞的功能
- 批准号:
8619514 - 财政年份:2013
- 资助金额:
$ 12.98万 - 项目类别:
Function of human regulatory cells in the intestinal mucosa of humanized mice
人类调节细胞在人源化小鼠肠粘膜中的功能
- 批准号:
8457624 - 财政年份:2013
- 资助金额:
$ 12.98万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 12.98万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 12.98万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 12.98万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 12.98万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 12.98万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 12.98万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 12.98万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 12.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 12.98万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 12.98万 - 项目类别: